Zur Kurzanzeige

Prognostische Bedeutung seltener Einzelchromosomenanomalien bei myelodysplastischen Syndromen

dc.contributor.advisorSchanz, Julie PD Dr.
dc.contributor.authorRothmann, Bärbel Christa Elfriede
dc.date.accessioned2020-01-03T11:06:51Z
dc.date.available2020-01-22T23:50:03Z
dc.date.issued2020-01-03
dc.identifier.urihttp://hdl.handle.net/21.11130/00-1735-0000-0005-12E2-7
dc.identifier.urihttp://dx.doi.org/10.53846/goediss-7792
dc.language.isodeude
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc610de
dc.titlePrognostische Bedeutung seltener Einzelchromosomenanomalien bei myelodysplastischen Syndromende
dc.typedoctoralThesisde
dc.title.translatedPrognostic impact of rare single chromosomatic anomalities at myelodysplastic syndromsde
dc.contributor.refereeHahn, Heidi Eva Prof. Dr.
dc.date.examination2020-01-15
dc.description.abstractengCytogenetic in myelodysplastic syndromes offer a valid prognostic factor for OS and AML free survival in the IPSS-R. For roughly 90% of cytogenetic abnormalities the prognostic impact is already known. This analysis therefore deals with some of these rare single abnormalities within the remaining 10%. More than 7000 cases where screened. Core results refer to the del(13q) and balanced translocations with a significantly better survival rate and to abnormalities at chromosomes 20 (without del (20q)) and patients with monosomie 9 which have a significantly shorter overall survival rate. For monosomie 9 patients and such with chromosome 20 abnormalities this applies for the AML free survival as well.de
dc.contributor.coRefereeSchön, Margarete Prof. Dr.
dc.subject.engmyelodysplastic syndromde
dc.subject.engrare single chromosomic abnormalitiesde
dc.identifier.urnurn:nbn:de:gbv:7-21.11130/00-1735-0000-0005-12E2-7-2
dc.affiliation.instituteMedizinische Fakultätde
dc.subject.gokfullMedizin (PPN619874732)de
dc.description.embargoed2020-01-22
dc.identifier.ppn1686426933


Dateien

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige